Recon HSS Launches Clinical Trial to Address Post-Traumatic Osteoarthritis after ACL Revision Surgery byTim AllenMay 20, 2024
Biologics Spine Bone Biologics Reports Progress With NB1 Clinical Program byJosh SandbergMarch 1, 2024
Biologics Spine BioRestorative Therapies to Present Preliminary BRTX-100 Clinical Data at the Orthopaedic Research Society (ORS) 2024 Annual Meeting byJosh SandbergFebruary 1, 2024
Spine Top Stories 3Spine Announces Completion of FDA Clinical Trial Enrollment Achieving 325 Surgeries in 2023 byJosh SandbergJanuary 10, 2024
Biologics Regulatory U.S. FDA Grants Lipogems® Second IDE Approval For A Clinical Trial On The Treatment For Knee OA byJosh SandbergOctober 4, 2023
Spine Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System byJosh SandbergOctober 4, 2023
Biologics Extremities Spine Theradaptive Awarded DOD Clinical Trial Award of up to $7.4 Million byJosh SandbergSeptember 26, 2023
Biologics Spine BioRestorative Therapies Announces Activation of Northwell Health in the Company’s Phase 2 Clinical Trial Targeting Chronic Lumbar Disc Disease byJosh SandbergSeptember 8, 2023
Neuro Spine Mainstay Medical Announces Completion of Enrollment of RESTORE Clinical Trial of ReActiv8® in the United States byJosh SandbergAugust 29, 2023
